Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Molecular evolution analysis of the human immunodeficiency virus type 1 envelope in simian/human immunodeficiency virus-infected macaques: implications for challenge dose selection.

Varela M, Landskron L, Lai RP, McKinley TJ, Bogers WM, Verschoor EJ, Dubbes R, Barnett SW, Frost SD, Heeney JL.

J Virol. 2011 Oct;85(19):10332-45. doi: 10.1128/JVI.05290-11. Epub 2011 Jul 27.

2.

CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.

Rutjens E, Mazza S, Biassoni R, Koopman G, Ugolotti E, Fogli M, Dubbes R, Costa P, Mingari MC, Greenwood EJ, Moretta L, De Maria A, Heeney JL.

Eur J Immunol. 2010 May;40(5):1440-50. doi: 10.1002/eji.200940062. Erratum in: Eur J Immunol. 2010 Jun;40(6):1819. DeMaria, Andrea [corrected to De Maria, Andrea].

3.

Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.

Bogers WM, Davis D, Baak I, Kan E, Hofman S, Sun Y, Mortier D, Lian Y, Oostermeijer H, Fagrouch Z, Dubbes R, van der Maas M, Mooij P, Koopman G, Verschoor E, Langedijk JP, Zhao J, Brocca-Cofano E, Robert-Guroff M, Srivastava I, Barnett S, Heeney JL.

Virology. 2008 Dec 20;382(2):217-25. doi: 10.1016/j.virol.2008.09.016. Epub 2008 Oct 22.

4.

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic.

Corbett M, Bogers WM, Heeney JL, Gerber S, Genin C, Didierlaurent A, Oostermeijer H, Dubbes R, Braskamp G, Lerondel S, Gomez CE, Esteban M, Wagner R, Kondova I, Mooij P, Balla-Jhagjhoorsingh S, Beenhakker N, Koopman G, van der Burg S, Kraehenbuhl JP, Le Pape A.

Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2046-51. doi: 10.1073/pnas.0705191105. Epub 2008 Feb 11.

5.

Readily acquired secondary infections of human and simian immunodeficiency viruses following single intravenous exposure in non-human primates.

ten Haaft P, Verschoor EJ, Verstrepen B, Niphuis H, Dubbes R, Koornstra W, Bogers W, Rosenwirth B, Heeney JL.

J Gen Virol. 2004 Dec;85(Pt 12):3735-45.

PMID:
15557247
6.

Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees.

ten Haaft P, Murthy K, Salas M, McClure H, Dubbes R, Koornstra W, Niphuis H, Davis D, van der Groen G, Heeney J.

AIDS. 2001 Nov 9;15(16):2085-92.

PMID:
11684927
7.

Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)).

Holterman L, Dubbes R, Mullins J, Learn G, Niphuis H, Koornstra W, Koopman G, Kuhn EM, Wade-Evans A, Rosenwirth B, Haaijman J, Heeney J.

J Virol. 2001 Oct;75(19):9328-38.

8.

The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques.

Holterman L, Niphuis H, Koornstra W, Dubbes R, ten Haaft P, Heeney JL.

J Gen Virol. 2000 Jul;81(Pt 7):1719-26.

PMID:
10859377
9.

A strategy for cloning infectious molecular clones of retroviruses from serum or plasma.

Holterman L, Dubbes R, Mullins J, Haaijman J, Heeney J.

J Virol Methods. 2000 Jan;84(1):37-48.

PMID:
10644085
10.

Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees.

Bogers WM, Koornstra WH, Dubbes RH, ten Haaft PJ, Verstrepen BE, Jhagjhoorsingh SS, Haaksma AG, Niphuis H, Laman JD, Norley S, Schuitemaker H, Goudsmit J, Hunsmann G, Heeney JL, Wigzell H.

J Gen Virol. 1998 Dec;79 ( Pt 12):2895-903.

PMID:
9880002
11.

Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta.

Bogers WM, Dubbes R, ten Haaft P, Niphuis H, Cheng-Mayer C, Stahl-Hennig C, Hunsmann G, Kuwata T, Hayami M, Jones S, Ranjbar S, Almond N, Stott J, Rosenwirth B, Heeney JL.

Virology. 1997 Sep 15;236(1):110-7.

12.

Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS.

Heeney J, Bogers W, Buijs L, Dubbes R, ten Haaft P, Koornstra W, Niphuis H, Nara P, Teeuwsen V.

Immunol Lett. 1996 Jun;51(1-2):45-52.

PMID:
8811344
13.

Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination.

ten Haaft P, Cornelissen M, Goudsmit J, Koornstra W, Dubbes R, Niphuis H, Peeters M, Thiriart C, Bruck C, Heeney JL.

J Gen Virol. 1995 Apr;76 ( Pt 4):1015-20.

PMID:
9049351
14.

Infectivity and virulence of cell-associated SIVmac after single passage in vivo.

Niphuis H, Dubbes RH, ten Haaft PJ, Koornstra WH, Bontrop RE, Cranage MP, Heeney JL.

AIDS. 1994 Dec;8(12):1730-1. No abstract available.

PMID:
7888125
15.

Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines.

de Vries P, Heeney JL, Boes J, Dings ME, Hulskotte EG, Dubbes R, Koornstra W, ten Haaft P, Akerblom L, Eriksson S, et al.

Vaccine. 1994 Nov;12(15):1443-52.

PMID:
7887023
16.

Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.

Heeney JL, van Els C, de Vries P, ten Haaft P, Otting N, Koornstra W, Boes J, Dubbes R, Niphuis H, Dings M, Cranage M, Norley S, Jonker M, Bontrop RE, Osterhaus A.

J Exp Med. 1994 Aug 1;180(2):769-74.

17.

Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge.

Heeney JL, Holterman L, ten Haaft P, Dubbes R, Koornstra W, Teeuwsen V, Bourquin P, Norley S, Niphuis H.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S117-21.

PMID:
7865285
18.

Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants.

Schuitemaker H, Meyaard L, Kootstra NA, Dubbes R, Otto SA, Tersmette M, Heeney JL, Miedema F.

J Infect Dis. 1993 Nov;168(5):1140-7.

PMID:
8228347
19.

The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction.

Heeney J, Jonker R, Koornstra W, Dubbes R, Niphuis H, Di Rienzo AM, Gougeon ML, Montagnier L.

J Med Primatol. 1993 Feb-May;22(2-3):194-200.

PMID:
8105093
20.

Isolation of uninfected immature hematopoietic cells from bone marrow of simian immunodeficiency virus infected rhesus monkeys.

van Wely M, Slachmuylders JF, Visser TP, Dubbes RH, Niphuis H, Heeney JL, Wagemaker G.

Transplant Proc. 1993 Feb;25(1 Pt 2):1279-80. No abstract available.

PMID:
7680153
21.

Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.

Heeney JL, de Vries P, Dubbes R, Koornstra W, Niphuis H, ten Haaft P, Boes J, Dings ME, Morein B, Osterhaus AD.

J Med Primatol. 1992 Feb-May;21(2-3):126-30.

PMID:
1433263
23.

Induction of haemopoietic tumours in rats by the type-C helper virus of the woolly monkey sarcoma virus.

Nooter K, Dubbes R, Jore J, Zurcher C.

Leuk Res. 1981;5(1):97-9. No abstract available.

PMID:
6262582
24.

Type-C virus antigen detection in co-cultures of human leukaemic bone marrow and dog cells.

Nooter K, Coolen J, Dubbes R, Zurcher C, Koch G, Bentvelzen P.

J Gen Virol. 1979 Dec;45(3):711-21.

PMID:
94349
25.

Type-C oncovirus isolate from human leukemic bone marrow: further in vitro and in vivo characterization.

Nooter K, Overdevest J, Dubbes R, Koch G, Bentvelzen P, Zurcher C, Coolen J, Calafat J.

Int J Cancer. 1978 Jan 15;21(1):27-34.

PMID:
203541

Supplemental Content

Loading ...
Support Center